252
Participants
Start Date
July 5, 2018
Primary Completion Date
July 31, 2024
Study Completion Date
September 12, 2024
BI 836880
intra-venous infusion
ezabenlimab
intra-venous infusion
National Taiwan University Hospital, Taipei
NCKUH, Tainan City
Royal North Shore Hospital-St Leonards-20807, St Leonards
Westmead Hospital, Westmead
Alfred Hospital, Melbourne
Kyiv City Clinical Oncological Center, Kyiv
Peninsula & South Eastern Oncology Group, Frankston
HOP Timone, Marseille
Seoul National University Bundang Hospital, Seongnam
Vinnytsia Regional Clinical Oncological Dispensary, Vinnytsia
CTR Georges-François Leclerc, Dijon
Virginia Cancer Specialists, PC, Fairfax
Winship Cancer Institute, Atlanta
CTR Eugène Marquis, Rennes
University of Alabama at Birmingham, Birmingham
Medical and Preventive Treatment Inst. Volyn Regional, Lutsk, Lutsk
HOP Nord Laennec, Saint-Herblain
Hospital Clínico de Valencia, Valencia
"Municipal Non-profit Enterprise City Clinical Hospital #4 of Dnipro City Council", Dnipropetrovks
Universitätsmedizin der Johannes Gutenberg-Universität Mainz, Mainz
Universitätsklinikum Frankfurt, Frankfurt am Main
HOP Civil, Strasbourg
INS Curie, Paris
Huntsman Cancer Institute, Salt Lake City
Universitätsklinikum Augsburg, Augsburg
Beverly Hills Cancer Center, Beverly Hills
Universitätsklinikum Regensburg, Regensburg
"JSC Group of Companies Medsi", Moscow
"SBHI Saint-Petersburg Clinical Research Center of Specialized Types of Medical Care (Oncological)", Saint Petersburg
"State Budget Healthcare Institution Volgograd Regional Clinical Oncology Dispensary", Volgograd
Dana-Farber Cancer Institute, Boston
Universitätsklinikum Carl Gustav Carus Dresden, Dresden
Queen Mary Hospital, Hong Kong
University Clinical Center, Gdansk, Gdansk
Mandziuk Slawomir Specialist Medical Practice, Lublin
European Health Center Otwock, Otwock
MED POLONIA SP Z O O, Clinical Trials Department,Poznan, Poznan
Dom Lekarski S.A., Szczecin
Seoul National University Hospital, Seoul
Asan Medical Center, Seoul
Hospital Vall d'Hebron-Barcelona-47683, Barcelona
Hospital Clínic de Barcelona, Barcelona
Royal Free Hospital, London
Lead Sponsor
Boehringer Ingelheim
INDUSTRY